Menovo is mainly engaged in the research and development, production and sales of pharmaceutical intermediates, specialty APIs and preparations. The existing intermediates and API products mainly cover multiple therapeutic fields such as cardiovascular, central nervous system, gastrointestinal digestive tract, endocrine, antiviral, antitumor. At the same time, the company is committed to establishing the world's leading API service (CM0/CDMO) platform to provide more customers with quality services. In the preparation business field, the company insists on the research and development and production of its own products,develops in-depth cooperation with strategic customers, integrates and optimizes industrial resources, and the results of integrated industrial upgrading have been quickly reflected. The leading products include Valsartan, Rosuvastatin, Atorvastatin, Clopidogrel, Perindopril and Esomeprazole and other APIs and intermediates.